These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8384655)

  • 1. Pathophysiological studies of neuromuscular function in subacute organophosphate poisoning induced by phosmet.
    Good JL; Khurana RK; Mayer RF; Cintra WM; Albuquerque EX
    J Neurol Neurosurg Psychiatry; 1993 Mar; 56(3):290-4. PubMed ID: 8384655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate syndrome due to prolonged parathion poisoning.
    De Bleecker J; Vogelaers D; Ceuterick C; Van Den Neucker K; Willems J; De Reuck J
    Acta Neurol Scand; 1992 Oct; 86(4):421-4. PubMed ID: 1455989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postsynaptic neuromuscular dysfunction in organophosphate induced intermediate syndrome.
    De Wilde V; Vogelaers D; Colardyn F; Vanderstraeten G; Van den Neucker K; De Bleecker J; De Reuck J; Van den Heede M
    Klin Wochenschr; 1991 Feb; 69(4):177-83. PubMed ID: 1645823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the organophosphate-induced electromyographic response to repetitive nerve stimulation: paradoxical response to edrophonium and D-tubocurarine.
    Maselli RA; Soliven BC
    Muscle Nerve; 1991 Dec; 14(12):1182-8. PubMed ID: 1662770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of an experimental distal motor axonopathy. Physiological studies of changes in neuromuscular transmission caused by cycloleucine, an inhibitor of methionine adenosyltransferase.
    Edwards JP; Lee CC; Duchen LW
    Brain; 1994 Oct; 117 ( Pt 5)():959-74. PubMed ID: 7953605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular transmission in amyotrophic lateral sclerosis.
    Maselli RA; Wollman RL; Leung C; Distad B; Palombi S; Richman DP; Salazar-Grueso EF; Roos RP
    Muscle Nerve; 1993 Nov; 16(11):1193-203. PubMed ID: 8105377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
    Thesleff SW
    Muscle Nerve; 1982; 5(9S):S12-6. PubMed ID: 6302487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of neostigmine on the motor endplate in the intermediate syndrome of organophosphate poisoning].
    Besser R
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1991 Mar; 22(1):37-9. PubMed ID: 1650695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital myasthenia: further evidence of disease heterogeneity.
    Lecky BR; Morgan-Hughes JA; Murray NM; Landon DN; Wray D; Prior C
    Muscle Nerve; 1986; 9(3):233-42. PubMed ID: 3010100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular transmission in the murine mutants "motor end-plate disease" and "jolting".
    Harris JB; Pollard SL
    J Neurol Sci; 1986 Dec; 76(2-3):239-53. PubMed ID: 3025377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology.
    Tiedt TN; Albuquerque EX; Hudson CS; Rash JE
    J Pharmacol Exp Ther; 1978 May; 205(2):326-39. PubMed ID: 205647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a neuromuscular disorder in methylmercury poisoning.
    Rustam H; Von Burg R; Amin-Zaki L; El Hassani S
    Arch Environ Health; 1975 Apr; 30(4):190-5. PubMed ID: 1091217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The repetitive muscular action potential in neuromuscular transmission disorders due to acetylcholinesterase inhibition].
    Besser R; Dillmann U; Gutmann L; Hopf HC
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1988 Jun; 19(2):85-91. PubMed ID: 2841086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The decrement-increment phenomenon in disorders of neuromuscular transmission by inhibition of acetylcholinesterase].
    Besser R; Hopf HC; Gutmann L; Dillmann U
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1989 Mar; 20(1):28-33. PubMed ID: 2539961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium-insensitive miniature endplate potentials at the neuromuscular junction.
    Lupa MT
    Synapse; 1987; 1(4):281-92. PubMed ID: 2843994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neostigmine myopathy is a calcium ion-mediated myopathy initially affecting the motor end-plate.
    Kawabuchi M
    J Neuropathol Exp Neurol; 1982 May; 41(3):298-314. PubMed ID: 6804607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurophysiological monitoring of pharmacological manipulation in acute organophosphate (OP) poisoning. The effects of pralidoxime, magnesium sulphate and pancuronium.
    Singh G; Avasthi G; Khurana D; Whig J; Mahajan R
    Electroencephalogr Clin Neurophysiol; 1998 Aug; 107(2):140-8. PubMed ID: 9751285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of poneratoxin on neuromuscular transmission in the rat diaphragm.
    Hendrich AB; Mozrzymas JW; Konopińska D; Scuka M
    Cell Mol Biol Lett; 2002; 7(2):195-202. PubMed ID: 12097919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
    Engel AG; Lambert EH; Gomez MR
    Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
    Kim YI; Goldner MM; Sanders DB
    Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.